In a research report released today, Cowen analyst Boris Peaker maintained an Outperform rating on shares of Heron Therapeutics Inc (NASDAQ:HRTX), and raised the …
In a research report released Tuesday, Cowen analyst Boris Peaker reiterated a Market Perform rating on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), after the company released …
Cowen & Co. analyst Boris Peaker initiated coverage on shares of Heron Therapeutics Inc (NASDAQ:HRTX) with an Outperform rating and a price target of …
Cowen & Co. analyst Boris Peaker came out with some commentary on Idera Pharmaceuticals Inc (NASDAQ:IDRA), following the company’s new-found research alliance with MD Anderson to test …
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) has been reiterated as a Buy at Cowen by research analyst Boris Peaker.
MEI Pharma Inc (NASDAQ:MEIP) shares are down almost 70% today following the news that the company's cancer drug Pracinostat failed to meet the primary endpoint of a Phase …
In a research report issued today, Cowen analyst Boris Peaker reiterated an Outperform rating on Celldex Therapeutics, Inc. (NASDAQ:CLDX) and raised the price target from $26 to …
Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares are up 17.
Cowen’s healthcare analyst Boris Peaker weighed in today with a few insights on Keryx Biopharmaceuticals (NASDAQ:KERX), following yesterday’s meeting with the company’s management team. The …
Cowen analyst Boris Peaker was out today with a research note on Keryx Biopharma (NASDAQ:KERX), following Friday’s release of IMS scripts data for Aurixya. The analyst rates …
